Article Menu
Need Help?
No Article Versions Notes Found
Cite
Sud, S.; O’Callaghan, C.; Jonker, C.; Karapetis, C.; Price, T.; Tebbutt, N.; Shapiro, J.; Van Hazel, G.; Pavlakis, N.; Gibbs, P.; et al. Hypertension as a Predictor of Advanced Colorectal Cancer Outcome and Cetuximab Treatment Response. Curr. Oncol. 2018, 25, 516-526. https://doi.org/10.3747/co.25.4069
Sud S, O’Callaghan C, Jonker C, Karapetis C, Price T, Tebbutt N, Shapiro J, Van Hazel G, Pavlakis N, Gibbs P, et al. Hypertension as a Predictor of Advanced Colorectal Cancer Outcome and Cetuximab Treatment Response. Current Oncology. 2018; 25(6):516-526. https://doi.org/10.3747/co.25.4069
Chicago/Turabian StyleSud, S., C. O’Callaghan, C. Jonker, C. Karapetis, T. Price, N. Tebbutt, J. Shapiro, G. Van Hazel, N. Pavlakis, P. Gibbs, and et al. 2018. "Hypertension as a Predictor of Advanced Colorectal Cancer Outcome and Cetuximab Treatment Response" Current Oncology 25, no. 6: 516-526. https://doi.org/10.3747/co.25.4069